Obed Boadi Amissah

Obed works around Cancer Immunotherapy where he applies the concept of T cell receptor's ability to recognize cancer biomarkers posing as peptide antigens on antigen presentation cells via major histocompatibility complex. Obed is able to re-engineer T cells to specifically kill cancer. He previously worked on carcinogenic mycotoxins that affects staples, he also worked at the pharmaceutical microbiology unit of the FDA, Ghana amongst other ISO:IEC accredited laboratories.